Ebasten50 ml

Ebasten 50 ml is indicated for the symptomatic treatment of: Seasonal and Perennial Allergic Rhinitis. Chronic Idiopathic Urticaria.

Non-sedating antihistamines

Ebasten 50 ml, a piperidine derivative, is a long-acting, nonsedating, second-generation histamine receptor antagonist that binds preferentially to peripheral H1 receptors. It is metabolised to active metabolite, carEbasten 50 ml. It has antihistaminic, antiallergic activity and prevents histamine-induced bronchoconstriction. It does not have significant sedative or antimuscarinic actions.

Tablet: Adults (more than 12 years of age): 10 mg (one tablet) once daily. Children (6-12 years of age): 5 mg (half tablet) once daily. Syrup: Children (2-5 years of age): 2.5 ml once daily (upto 5 ml in severe cases such as Perennial Allergic Rhinitis). Children (6-12 years of age): 5 ml once daily (upto 10 ml in severe cases such as Perennial Allergic Rhinitis). Ebasten 50 ml may be taken with or without food.

Ebasten 50 ml may be taken with or without food.

Ebasten 50 ml in combination with either ketoconazole or erythromycin increases in plasma level of Ebasten 50 ml and prolonged QTc interval. Ebasten 50 ml does not interact with the pharmacokinetics of theophylline, warfarin, cimetidine, diazepam or alcohol. The sedation effect of alcohol and diazepam may be enhanced.

Patients with a known hypersensitivity to Ebasten 50 ml or any of its ingredients.

The most common side-effects are headache, dry mouth and drowsiness. Less commonly reported side effects include abdominal pain, dyspepsia, nausea and insomnia.

The safety of Ebasten 50 ml during pregnancy and lactation has not been established.

It is advisable to exercise caution when using Ebasten 50 ml in patients known to have the following conditions: long QT syndrome, hypokalaemia, treatment with any medicine known to produce an increase in QT interval or inhibit CYP3A4 enzyme systems such as azole antifungals and macrolide antibiotics. Use in Pregnancy and Lactation The safety of Ebasten 50 ml during pregnancy and lactation has not been established. Ebasten 50 ml should not be used during pregnancy only if clearly needed. It is not known whether Ebasten 50 ml is excreted in milk, therefore, Ebasten 50 ml should not be used during lactation.

No clinically meaningful signs or symptoms were observed up to 100 mg given once daily. There is no specific antidote for Ebasten 50 ml. In case of accidental overdoses, gastric lavage, monitoring of vital functions including ECG and symptomatic treatment should be carried out.

Store below 30°C at a cool and dry place, away from light. Keep out of reach of children

Non-sedating antihistamines

Ebasten 50 ml is a long-acting and selective H1-histamine receptor antagonist. After repeated administration, inhibition of peripheral receptors remains at a constant level. Ebasten 50 ml is rapidly absorbed and undergoes extensive first-pass metabolism following oral administration. Ebasten 50 ml is almost totally converted to the pharmacologically active acid metabolite, carEbasten 50 ml.